Richard Graham, MD
- Member, Division of Oncology
- Assistant Professor, UC Department of Pediatrics
- richard.graham@cchmc.org
- Board Certified
About
Biography
As a neuro-oncologist, I specialize in treating brain tumors. When I treat a person with a brain tumor, I want to help them and their family make the most of their lives.
Brain tumors represent a convergence of some of the most important questions in science and some of the most challenging situations in life. New research on the molecular mechanisms underlying the development of tumors is opening up opportunities to target those tumors in ways that haven't been explored yet. At the same time, families impacted by brain tumors find themselves in a situation that can be overwhelmingly unfamiliar and difficult. This exciting research and a desire to help these families is why I chose to be a neuro-oncologist.
In my research, we are trying to use new tools to understand the molecular machinery that makes tumors work so we can target those mechanisms specifically with as little risk as possible to the patient.
My own children remind me that life is too important not to have fun and spend time with the people you love. We don't have any trouble filling our "spare" time!
Services and Specialties
Research Areas
Additional Languages
SpanishLocations (2)
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
MEK inhibitor-induced dropped head syndrome in pediatrics. Neuro-Oncology Pediatrics. 2026; 2(2):wuag024.
Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors. Journal of Neuro-Oncology. 2026; 177(3).
Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma. Neuro-Oncology. 2026; 28(2):535-551.
Diagnostic pitfall: BCOR immunoreactivity in a molecularly confirmed astroblastoma, MN1-altered (HGNET-MN1). Clinical Neuropathology. 2026; 45(1):32-35.
Disseminated pediatric low-grade glioma and hydrocephalus: a multinational consortium analysis of incidence and mortality. Journal of Neurosurgery: Pediatrics. 2025; 37(2):133-146.
BIOM-88. LEPTOMENINGEAL METASTASIS IN THE INTERNAL AUDITORY CANAL AS A PREDICTOR OF OUTCOMES FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMORS. Neuro-Oncology. 2025; 27(Supplement_5):v45-v45.
PA2G4 as a Candidate Therapeutic Target in Pediatric Diffuse Gliomas. International Journal of Radiation Oncology Biology Physics. 2025; 123(1):e510.
Elevated Bromide Levels Due to Tazemetostat Therapy Treated With Salt and Water Supplementation in Two Children With Atypical Teratoid Rhabdoid Tumor. Pediatric Blood and Cancer. 2025; 72(8):e31803.
GCT-29. MULTI-INSTITUTIONAL ANALYSIS OF PEDIATRIC RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM GERMINOMAS. Neuro-Oncology. 2024; 26(Supplement_4):0-0.
GCT-21. MULTINATIONAL ANALYSIS OF PEDIATRIC RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM NON-GERMINOMATOUS GERM CELL TUMORS. Neuro-Oncology. 2024; 26(Supplement_4):0-0.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 2026 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey